Harbor Investment Advisory’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.55K | Hold |
500
| – | – | ﹤0.01% | 1097 |
|
|
2025
Q1 | $1.75K | Hold |
500
| – | – | ﹤0.01% | 1086 |
|
|
2024
Q4 | $1.64K | Hold |
500
| – | – | ﹤0.01% | 1066 |
|
|
2024
Q3 | $1.93K | Sell |
500
-303
| -38% | -$1.17K | ﹤0.01% | 1065 |
|
|
2024
Q2 | $2.48K | Hold |
803
| – | – | ﹤0.01% | 1046 |
|
|
2024
Q1 | $2.07K | Hold |
803
| – | – | ﹤0.01% | 1102 |
|
|
2023
Q4 | $2.01K | Hold |
803
| – | – | ﹤0.01% | 1049 |
|
|
2023
Q3 | $1.63K | Hold |
803
| – | – | ﹤0.01% | 1065 |
|
|
2023
Q2 | $1.85K | Hold |
803
| – | – | ﹤0.01% | 1222 |
|
|
2023
Q1 | $2.43K | Buy |
803
+303
| +61% | +$918 | ﹤0.01% | 1201 |
|
|
2022
Q4 | $1.17K | Hold |
500
| – | – | ﹤0.01% | 1240 |
|
|
2022
Q3 | $1K | Hold |
500
| – | – | ﹤0.01% | 1253 |
|
|
2022
Q2 | $1K | Hold |
500
| – | – | ﹤0.01% | 1269 |
|
|
2022
Q1 | $1K | Hold |
500
| – | – | ﹤0.01% | 1278 |
|
|
2021
Q4 | $2K | Hold |
500
| – | – | ﹤0.01% | 1204 |
|
|
2021
Q3 | $2K | Hold |
500
| – | – | ﹤0.01% | 1215 |
|
|
2021
Q2 | $2K | Hold |
500
| – | – | ﹤0.01% | 1157 |
|
|
2021
Q1 | $2K | Hold |
500
| – | – | ﹤0.01% | 1141 |
|
|
2020
Q4 | $2K | Hold |
500
| – | – | ﹤0.01% | 1076 |
|
|
2020
Q3 | $2K | Sell |
500
-500
| -50% | -$2K | ﹤0.01% | 999 |
|
|
2020
Q2 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 958 |
|
|
2020
Q1 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 952 |
|
|
2019
Q4 | $3K | Buy |
+1,000
| New | +$3K | ﹤0.01% | 732 |
|